Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: gefitinib|PROCEDURE: Surgery
Sponsor: Vanderbilt-Ingram Cancer Center
Collaborators: National Cancer Institute (NCI)